Results 91 to 100 of about 94,546 (247)
Hormone therapy for first-line management of menopausal symptoms: Practical recommendations
Women's Health, 2019 Hormone therapy use has undergone dramatic changes over the past 20 years. Widespread use of hormone therapy in the 1980s and 1990s came to an abrupt halt in the early 2000s after initial findings of the Women’s Health Initiative trial were published and
Santiago Palacios +4 more
doaj +1 more source
WISDOM: history and early demise - was it inevitable?
, 2007 In 1989, the UK Medical Research Council (MRC) agreed that, if feasible, a randomized controlled trial to assess the long-term risks and benefits of hormone replacement therapy (HRT) was a priority.
Darbyshire, J, Meade, T, Vickers, M
core +1 more source
Estrogens promote misfolded proinsulin degradation to protect insulin production and delay diabetes [PDF]
, 2018 Summary: Conjugated estrogens (CE) delay the onset of type 2 diabetes (T2D) in postmenopausal women, but the mechanism is unclear. In T2D, the endoplasmic reticulum (ER) fails to promote proinsulin folding and, in failing to do so, promotes ER stress and
Allard, Camille +12 more
core +2 more sources
Репродуктивная эндокринология, 2017 The hormone therapy remains the most effective method for treating of the vasomotor symptoms and genitourinary syndrome in menopause. The evidence available to date suggests that for women younger than 60 and with a postmenopause no more than 10 years ...
С. О. Шурпяк
doaj +1 more source
Risk of cancer after assisted reproduction: a review of the available evidences and guidance to fertility counselors [PDF]
, 2018 Infertile women requiring ovarian stimulation and assisted reproduction techniques (ART) are faced with difficult issues. The fear that using hormones could increase their risk of cancer is the most significant.
Codacci-Pisanelli, G +4 more
core +1 more source
High serum osteopontin levels are associated with prevalent fractures and worse lipid profile in post-menopausal women with type 2 diabetes [PDF]
, 2018 Purpose: Patients with type 2 diabetes (T2DM) have increased fracture risk. Osteopontin (OPN) is a protein involved in bone remodeling and inflammation.
Carnevale, V. +9 more
core +1 more source
BreastPurpose: Hormone receptor-positive breast cancer survivors undergoing endocrine therapy face significant body image challenges. This study aimed to examine differences in body image between hormone receptor-positive breast cancer survivors receiving ...
Oshri Saar Sheffi +4 more
doaj +1 more source
The choice of hormonal and alternative therapy in menopausal and post-menopausal period [PDF]
РМЖ. Мать и дитя, 2018 The choice of hormonal and alternative therapy in menopausal and post-menopausal period Kuznetsova I.V. First Moscow State Medical University named after I.M.Sechenov (Sechenov University), Moscow Menopause is a key moment in the aging of a female
Kuznetsova I.V.
doaj
Menopausal metabolic syndrome and the risks of menopausal hormone therapy: the solutions [PDF]
РМЖ. Мать и дитя, 2020 A.E. Esedova1, N.G. Urudzheva1, I.Yu. Il’ina2 1Dagestan State Medical University, Makhachkala, Russian Federation 2Pirogov Russian National Research Medical University, Moscow, Russian Federation Climacteric is a physiological period of woman ...
A.E. Esedova +2 more
doaj